Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ClpX is an AAA+ ATPase protein and acts as a molecular chaperone and substrate specificity component of the ATP-dependent ClpXP protease system in Helicobacter pylori[2][5][6]. It partners with the serine protease ClpP to recognize, unfold, and translocate misfolded, damaged, or regulatory proteins into the proteolytic chamber of ClpP for degradation via ATP hydrolysis. ClpX has inherent ATPase and chaperone activities even in the absence of ClpP, functioning in bacterial stress responses and protein quality control[1][5]. ClpX and its associated Clp protease system are crucial for bacterial survival, pathogenicity, and adaptation, representing a promising antibacterial drug target although no clinically approved drugs are currently known to inhibit H. pylori ClpX directly[4]. The dysfunction of ClpX impairs H. pylori's ability to manage protein stress and express virulence factors, making it a focus of research in infection control.
ATP-dependent protein unfolding Substrate recognition and translocation into ClpP for proteolysis[2][3][5][6] Chaperone-mediated prevention of protein aggregation under stress
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-dependent Clp protease ATP-binding subunit ClpX (ClpX).